ArticleFrontiers in nutrition2025
The brand-new predictor index of fulminant process in patients with acute myocarditis: hemoglobin, albumin, lymphocyte and platelet (HALP) score.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical significance of geriatric nutritional risk index in risk stratification of acute myocarditis.Heart and vessels · 2026Article
- Prognostic role of hemoglobin, albumin, lymphocyte and platelet score in esophageal cancer: a systematic review and meta-analysis.Journal of thoracic disease · 2026Article
- A novel evaluation indicator for pediatric fulminant myocarditis: diagnostic and prognostic value of the HALP score.BMC pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objectives: Myocarditis can progress to a fulminant form, leading to severe heart failure and mortality. Inflammation and nutritional status play critical roles in disease progression. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel, easily accessible biomarker that reflects both systemic inflammation and nutritional status. This study aimed to evaluate the prognostic value of the HALP score in predicting fulminant myocarditis among patients diagnosed with acute myocarditis. Methods: A total of 124 patients diagnosed with acute myocarditis were retrospectively enrolled in this single-center study. Patients were categorized into non-fulminant and fulminant myocarditis groups based on diagnostic criteria. Results: The median age of the patients was 24 years, 14.5% was female. Twenty-three of these patients (18.5%) exhibited fulminant myocarditis. Troponin I, C-reactive protein (CRP), white blood cell (WBC), and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were significantly higher in the fulminant myocarditis group, while the HALP score was lower ( Conclusion: The HALP score can independently predict the development of fulminant myocarditis in acute myocarditis patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.